All biotech drug firms except 1 that I know of (one that I bough in 2009 at the bottom, Novartis) have been hammered just as much as $RVVTF, in part because of the highs they all saw from the pandemic and cheap interest free money... during quarantines. But Novartis was part of the pandemic rally. It did creep up and make about 4-6 year high this month.
It is also sector wide and tied to money tightening by the FED at a near 40 year record rate of interest rate increases, that sent them all way back down. The price being down for $RVVTF right now is not about $RVVTF. It is a sector wide issue, % down factor.. And is also tied to sector ETFs ..of which RVVTF is in one...
Market Data 
Markets 
AI
